Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-754-4 | CAS number: 540-72-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09 March, 2016 - 10 March, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- (2012)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- Version / remarks:
- (2008)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2400 (Acute Eye Irritation)
- Version / remarks:
- (1998)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF Guidelines (2000), including the most recent revisions.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Sodium thiocyanate
- Appearance: White crystals
- Batch: 1510071519
- Purity/Composition: 99.9%
- Test item storage: At room temperature
- Stable under storage conditions: until 25 November 2018 (retest date)
Certificate of Analysis included in report
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Charles River France, L’Arbresle Cedex, France.
- Age at study initiation: 20 weeks
- Weight at study initiation: 4.315 kg
- Housing: Animals were individually housed in labeled cages with perforated floors
- Diet: Free access to pelleted diet for rabbits (Global Diet 2030 Harlan Teklad®, Italy). Hay and wooden sticks were available during the study period.
- Water: Free access to tap water.
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): set to maintain 18 – 24
- Humidity (%): set to maintain 40 - 70
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12/12
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: One eye of each animal remained untreated and served as the reference control.
- Amount / concentration applied:
- TEST MATERIAL
- ground to a powder using a mortar and pestle prior to weighing.
- Amount applied: 60.7 mg (volume of approximately 0.1 mL) - Duration of treatment / exposure:
- Single instillation on Day 1.
- Observation period (in vivo):
- The eyes of each animal were examined approximately 1 and 24 hours after instillation of the test substance.
- Number of animals or in vitro replicates:
- 1 female
- Details on study design:
- STUDY DESIGN
The study was performed in a stepwise manner and was started by treatment of a single rabbit (sentinel). Based on the severity of the ocular lesions observed during the study, the animal was sacrificed for ethical reasons immediately after the 24 hours observation and the two further rabbits assigned to the study were not treated.
PREEMPTIVE PAIN MANAGEMENT
One hour prior to instillation of the test substance, buprenorphine (Buprenodale®, Dechra Ltd., Stokeon-Trent, United Kingdom) 0.01 mg/kg bw was administered by subcutaneous injection in order to provide a therapeutic level of systemic analgesia.
Five minutes prior to instillation of the test substance, two drops of the topical anesthetic alcaine 0.5% (SA Alcon-Couvreur NV, Puurs, Belgium) were applied to both eyes.
TREATMENT
The animal was treated by instillation of, 60.7 mg of the test item (a volume of approximately 0.1 mL), in the conjunctival sac of one of the eyes after gently pulling the lower lid away from the eyeball. The lids were then gently held together for about one second to prevent loss of the test item. The other eye remained untreated and served as the reference control.
Immediately after the 24-hour observation, a solution of 2% fluorescein (Merck, Darmstadt, Germany) in water (adjusted to pH 7.0) was instilled into both eyes of each animal to quantitatively determine corneal epithelial damage. Any bright green stained area, indicating epithelial damage, was estimated as a percentage of the total corneal area.
Immediately after fluorescein examination on Day 2, in order to provide a continued level of systemic analgesia, buprenorphine 0.01 mg/kg and meloxicam (Metacam®, Boehringer Vetmed GmbH, Ingelheim/Rhein, Germany) 0.5 mg/kg were administered by subcutaneous injection.
Additional injections were supplied during the observation period to reduce pain and distress After the final observation, the animal was sacrificed by intra-venous injection of Euthasol® 20% (AST Farma BV, Oudewater, The Netherlands).
REMOVAL OF TEST SUBSTANCE
-Washing: No
OBSERVATIONS
- Mortality/Viability: Twice daily.
- Toxicity: At least once daily.
- Body Weight: Day of treatment (prior to instillation) and on day of the final observation.
- Necropsy: No necropsy was performed according to protocol.
- The eyes of the animal were examined approximately 1 and 24 after instillation of the test item. The irritation scores and a description of all other (local) effects were recorded. The irritation was assessed according to OECD 405.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Remarks:
- (opacity)
- Basis:
- animal #1
- Time point:
- other: 24 hrs.
- Score:
- 2
- Max. score:
- 4
- Remarks on result:
- other: Animal sacrificed after 24 hrs
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- other: 24 hrs.
- Score:
- 1
- Max. score:
- 2
- Remarks on result:
- other: Animal sacrificed after 24 hrs
- Irritation parameter:
- conjunctivae score
- Remarks:
- (redness)
- Basis:
- animal #1
- Time point:
- other: 24 hrs.
- Score:
- 3
- Max. score:
- 3
- Remarks on result:
- other: Animal sacrificed after 24 hrs
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- other: 24 hrs.
- Score:
- 4
- Max. score:
- 4
- Remarks on result:
- other: Animal sacrificed after 24 hrs
- Irritant / corrosive response data:
- Instillation of 61 mg of Sodium thiocyanate (a volume of approximately 0.1 mL) into an eye of one rabbit resulted in severe effects ocular effects and signs of discomfort of the animal (tilted head) necessitating the sacrifice the animal for humane reasons at 24 hours after instillation. The signs consisted of grey/white discouloration (sign of necrosis) of the eyelids and nictitating membrane. Moreover, injuries of the cornea and iris were noted. Corneal injury consisted of opacity and epithelial damage. Further, at 24 hours after dosing red discolouration of the lachrymal fluid was noted.
- Other effects:
- No staining of (peri) ocular tissues by the test substance was observed and no test substance remnants were seen.
No effects on Body weight was shown by the animal.
No further signs of systemic toxicity were observed in the animal during the test period and no mortality occurred.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- In an eye irritation study with a male rabbit with Sodium thiocyanate, performed according to OECD 405 test guideline, occular corrosion was observed.
- Executive summary:
The acute eye irritation/corrosion of Sodium thiocyanate was determined in accordance with OECD 405 (2012) and according to GLP principles. A single sample of 61 mg (a volume of approximately 0.1 mL) of Sodium thiocyanate was instilled into an eye of one rabbit. Observations were made 1 and 24 hours after instillation.
Instillation of 61 mg of Sodium thiocyanate (a volume of approximately 0.1 mL) into an eye of one rabbit resulted in severe effects ocular effects and signs of discomfort of the animal (tilted head) necessitating the sacrifice the animal for humane reasons at 24 hours after instillation. The signs consisted of grey/white discouloration (sign of necrosis) of the eyelids and nictitating membrane. Moreover, injuries of the cornea and iris were noted. Corneal injury consisted of opacity and epithelial damage. Further, at 24 hours after dosing red discolouration of the lachrymal fluid was noted.
Based on the results, Sodium thiocyanate should be classified as Irreversible effects on the eye (Category 1) and labeled as H318: Causes serious eye damage, according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.